Bendamustine, Mitoxantrone, Rituximab (BMR)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bendamustine, Mitoxantrone, Rituximab (BMR), covering 2020-04-03 to 2020-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma [Phase 2]